Transgenic mouse models of neurodegenerative disease: Opportunities for therapeutic development

This publication has 67 references indexed in Scilit:

• Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease
  Annals of Neurology, 2001
• Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
  Published by Elsevier ,2001
• Reduction of Aβ accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidylinositol kinase inhibitor wortmannin
  The FASEB Journal, 2000
• Neuroinvasion of Prions: Insights from Mouse Models
  Experimental Physiology, 2000
• Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
  Science, 1997
• Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice
  Cell, 1996
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
  Neuron, 1996
• The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
  Biochemistry, 1993
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
  Nature, 1993
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
  Biochemical and Biophysical Research Communications, 1984